Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Fig 4

Research Article

Targeting Ovarian Cancer Cell Cytotoxic Drug Resistance Phenotype with Xanthium strumarium L. Extract

Figure 4

XFC extract alters ES-2 and SKOV-3 cell cycle division. Human ovarian clear cell carcinoma (ES-2) and human ovarian adenocarcinoma (SKOV-3) cells were cultured, followed by treatments with various concentrations of XFC in serum-free media for 24 hours, fixation, and by PI staining. (a) Data acquisition was performed by flow cytometry as described in Section 2 in order to assess cell cycle phases. (b) Data analysis was also performed in order to assess the levels of cells in sub-G1, G0/G1, S, and G2/M phases. Significance: , , versus the negative control.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.